Clinical Trials Browser

Phase 1/2 × APG-1387 × 90 days × Clear all

NCT04284488 2026-01-08

Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors

Phase 1/2 Terminated

Other solid neoplasm

Advanced Solid Tumor

NCT04643405 2026-01-08

APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma

Phase 1/2 Terminated

Gastrointestinal

Pancreatic Neoplasms